Saggese G, Cesaretti G, Di Spigno G, Cinquanta L, Giannessi N, Cioni C, Bracaloni C
Clinica Pediatrica I, Università di Pisa, Italia.
Pediatr Med Chir. 1990 Sep-Oct;12(5):483-8.
We have evaluated thyroid and thyrotropin functions before the beginning and during Growth Hormone (GH) treatment for a 2-6-year period in a group composed of 21 children (age: 6.6 +/- 1.1 years, m +/- SD) suffering from classic GH deficiency. Circulating levels of thyroxine, and basal thyroid-stimulating hormone (TSH) always resulted in the normal range. TSH response to thyreotropin-releasing hormone administration showed in some subjects (one out of 21 before the start of treatment, 2 out of 16 after 2 years, 3 out of 12 after 4 years and 2 out of 10 after 6 years) a delayed (after 90-120 minutes) and higher peak in comparison to that of normal subjects. All these high and delayed values have been showed in only one occasion by different children, with the exception of a child who has presented the higher values in two occasions. Growth response to GH treatment has not been modified by the change in thyrotropin response, as subjects with high TSH peak have had a height velocity similar to that of the other children in the corresponding periods of study.
我们在一组21名患有典型生长激素缺乏症的儿童(年龄:6.6±1.1岁,均值±标准差)中,于生长激素(GH)治疗开始前及治疗2至6年期间评估了甲状腺和促甲状腺激素功能。甲状腺素和基础促甲状腺激素(TSH)的循环水平始终处于正常范围。对促甲状腺激素释放激素给药的TSH反应在一些受试者中(治疗开始前21名中有1名,2年后16名中有2名,4年后12名中有3名,6年后10名中有2名)显示出与正常受试者相比延迟(90 - 120分钟后)且峰值更高。所有这些高值和延迟值仅在不同儿童的一次检测中出现,除了一名儿童在两次检测中均出现了较高值。促甲状腺素反应的变化并未改变对GH治疗的生长反应,因为TSH峰值高的受试者在相应研究期间的身高增长速度与其他儿童相似。